Minerva Neurosciences, Inc. ( NERV) - Stock Earnings

NERV Quarterly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2025Q4 -283.7 million USD — USD
2026Q1 -125.4 million USD — USD
2026Q2 17.5 million USD — USD
2026Q3 Est.
2026Q4 Est.
2027Q1 Est.

NERV Yearly earnings

Analyst consensus estimates are available to paid members.

DateEarningsRevenue
2023 -30.0 million USD — USD
2024 1.4 million USD — USD
2025 -293.4 million USD — USD
2026 Est.

NERV

Price: $4.44

52 week price:
1.76
12.46

Earnings Per Share: -40.15 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 48300

Ebitda: -11.1 million

Market Capitalization: 220.6 million

Links: